Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Review Article

Management of Anaphylaxis in Pediatric Population

Author(s): Tuğba Arıkoğlu, Aylin Kont Ozhan and Semanur Kuyucu*

Volume 29, Issue 3, 2023

Published on: 24 November, 2022

Page: [209 - 223] Pages: 15

DOI: 10.2174/1381612829666221021154032

Price: $65

Abstract

Although an increase in the incidence of childhood anaphylaxis has been reported, it remains underdiagnosed. Foods are the most common triggers for anaphylaxis, particularly cow’s milk, hen’s egg, and nuts. Other common causes of anaphylaxis in children and adolescents include venom and drugs. The skin is the most commonly affected organ, but approximately 10% of patients with anaphylaxis may present without skin symptoms, which can lead to misdiagnosis. Recognition of anaphylaxis is a great challenge in children, possibly due to a lack of vigilance among patients, caregivers, and healthcare professionals, but also in part due to discrepancies in the clinical definition of anaphylaxis. In addition, anaphylaxis in infants often poses a distinct challenge because the wide spectrum of clinical manifestations and the inability of infants to describe their symptoms may hinder prompt diagnosis and treatment. Given the rapid onset of anaphylaxis and its unpredictable severity, rapid assessment and appropriate treatment are critical. Although the morbidity and mortality associated with anaphylaxis are potentially preventable with the timely administration of life-saving epinephrine, anaphylaxis is still undertreated worldwide. Long-term management of pediatric anaphylaxis is a patientcentered, multidimensional approach that focuses on the recognition of anaphylaxis, the use of epinephrine auto- injectors, and prevention of recurrences. Therefore, close communication and collaboration between the child, caregivers, healthcare professionals, and schools are the cornerstone of long-term care. This paper is designed to provide a comprehensive overview of current perspectives and concepts related to anaphylaxis in the pediatric population in light of recent guidelines and literature.

« Previous Next »
[1]
Tanno LK, Demoly P. Anaphylaxis in children. Pediatr Allergy Immunol 2020; 31(S26): 8-10.
[http://dx.doi.org/10.1111/pai.13336] [PMID: 33236416]
[2]
Nagakura KI, Sato S, Asaumi T, Yanagida N, Ebisawa M. Novel insights regarding anaphylaxis in children-with a focus on prevalence, diagnosis, and treatment. Pediatr Allergy Immunol 2020; 31(8): 879-88.
[http://dx.doi.org/10.1111/pai.13307] [PMID: 32519391]
[3]
Muraro A, Worm M, Alviani C, et al. EAACI guideline: Anaphylaxis (2021 update). Allergy 2021.
[http://dx.doi.org/10.1111/all.15032] [PMID: 34343358]
[4]
Greenhawt M, Gupta RS, Meadows JA, et al. Guiding principles for the recognition, diagnosis, and management of infants with anaphylaxis: An expert panel consensus. J Allergy Clin Immunol Pract 2019; 7(4): 1148-1156.e5.
[http://dx.doi.org/10.1016/j.jaip.2018.10.052] [PMID: 30737191]
[5]
Sampson HA, Muñoz-Furlong A, Campbell RL, et al. Second symposium on the definition and management of anaphylaxis: Summary report - second national institute of allergy and infectious disease/food allergy and anaphylaxis network symposium. J Allergy Clin Immunol 2006; 117(2): 391-7.
[http://dx.doi.org/10.1016/j.jaci.2005.12.1303] [PMID: 16461139]
[6]
Cardona V, Ansotegui IJ, Ebisawa M, et al. World allergy organization anaphylaxis guidance 2020. World Allergy Organ J 2020; 13(10): 100472.
[http://dx.doi.org/10.1016/j.waojou.2020.100472] [PMID: 33204386]
[7]
Poowuttikul P, Seth D. Anaphylaxis in children and adolescents. Immunol Allergy Clin North Am 2021; 41(4): 627-38.
[http://dx.doi.org/10.1016/j.iac.2021.07.009] [PMID: 34602233]
[8]
Muraro A, Roberts G, Worm M, et al. Anaphylaxis: Guidelines from the European Academy of Allergy and Clinical Immunology. Allergy 2014; 69(8): 1026-45.
[http://dx.doi.org/10.1111/all.12437] [PMID: 24909803]
[9]
Pouessel G, Turner PJ, Worm M, et al. Food-induced fatal anaphylaxis: From epidemiological data to general prevention strategies. Clin Exp Allergy 2018; 48(12): 1584-93.
[http://dx.doi.org/10.1111/cea.13287] [PMID: 30288817]
[10]
Greenhawt M, Wallace D, Sublett JW, et al. Current trends in food allergy–induced anaphylaxis management at school. Ann Allergy Asthma Immunol 2018; 121(2): 174-8.
[http://dx.doi.org/10.1016/j.anai.2018.04.015] [PMID: 29684568]
[11]
Wang Y, Allen KJ, Suaini NHA, McWilliam V, Peters RL, Koplin JJ. The global incidence and prevalence of anaphylaxis in children in the general population: A systematic review. Allergy 2019; 74(6): 1063-80.
[http://dx.doi.org/10.1111/all.13732] [PMID: 30688375]
[12]
Wang Y, Koplin JJ, Ho MHK, Wong WHS, Allen KJ. Increasing hospital presentations for anaphylaxis in the pediatric population in Hong kong. J Allergy Clin Immunol Pract 2018; 6(3): 1050-1052.e2.
[http://dx.doi.org/10.1016/j.jaip.2017.09.018] [PMID: 29109048]
[13]
Bohlke K, Davis RL, DeStefano F, Marcy SM, Braun MM, Thompson RS. Epidemiology of anaphylaxis among children and adolescents enrolled in a health maintenance organization. J Allergy Clin Immunol 2004; 113(3): 536-42.
[http://dx.doi.org/10.1016/j.jaci.2003.11.033] [PMID: 15007358]
[14]
Tejedor Alonso MA, Moro Moro M, Múgica García MV. Epidemiology of anaphylaxis. Clin Exp Allergy 2015; 45(6): 1027-39.
[http://dx.doi.org/10.1111/cea.12418] [PMID: 25495512]
[15]
Grabenhenrich LB, Dölle S, Moneret-Vautrin A, et al. Anaphylaxis in children and adolescents: The European anaphylaxis registry. J Allergy Clin Immunol 2016; 137(4): 1128-1137.e1.
[http://dx.doi.org/10.1016/j.jaci.2015.11.015] [PMID: 26806049]
[16]
Turner PJ, Gowland MH, Sharma V, et al. Increase in anaphylaxis-related hospitalizations but no increase in fatalities: A analysis of united Kingdom national anaphylaxis data, 1992-2012. J Allergy Clin Immunol 2015; 135(4): 956-963.e1.
[http://dx.doi.org/10.1016/j.jaci.2014.10.021] [PMID: 25468198]
[17]
Mullins RJ, Dear KBG, Tang MLK. Time trends in Australian hospital anaphylaxis admissions in 1998-1999 to 2011-2012. J Allergy Clin Immunol 2015; 136(2): 367-75.
[http://dx.doi.org/10.1016/j.jaci.2015.05.009] [PMID: 26187235]
[18]
Rudders SA, Banerji A, Clark S, Camargo CA Jr. Age-related differences in the clinical presentation of food-induced anaphylaxis. J Pediatr 2011; 158(2): 326-8.
[http://dx.doi.org/10.1016/j.jpeds.2010.10.017] [PMID: 21094954]
[19]
Erdem SE, Karaman S, Nacaroğlu HT, et al. Risk group in anaphylaxis: Infant anaphylaxis. Asthma Allergy Immunol 2016; 14: 31-6.
[20]
Parlaman JP, Oron AP, Uspal NG, DeJong KN, Tieder JS. Emergency and hospital care for food-related anaphylaxis in children. Hosp Pediatr 2016; 6(5): 269-74.
[http://dx.doi.org/10.1542/hpeds.2015-0153] [PMID: 27102912]
[21]
Motosue MS, Bellolio MF, Van Houten HK, Shah ND, Campbell RL. Increasing emergency department visits for anaphylaxis, 2005-2014. J Allergy Clin Immunol Pract 2017; 5(3): 171-5.
[22]
Nocerino R, Leone L, Cosenza L, Berni Canani R. Increasing rate of hospitalizations for food-induced anaphylaxis in Italian children: An analysis of the italian ministry of health database. J Allergy Clin Immunol 2015; 135(3): 833-835.e3.
[http://dx.doi.org/10.1016/j.jaci.2014.12.1912] [PMID: 25630939]
[23]
Simons FER. Anaphylaxis. J Allergy Clin Immunol 2010; 125(2): S161-81.
[http://dx.doi.org/10.1016/j.jaci.2009.12.981] [PMID: 20176258]
[24]
Ma L, Danoff TM, Borish L. Case fatality and population mortality associated with anaphylaxis in the United States. J Allergy Clin Immunol 2014; 133(4): 1075-83.
[http://dx.doi.org/10.1016/j.jaci.2013.10.029] [PMID: 24332862]
[25]
Mullins RJ, Wainstein BK, Barnes EH, Liew WK, Campbell DE. Increases in anaphylaxis fatalities in Australia from 1997 to 2013. Clin Exp Allergy 2016; 46(8): 1099-110.
[http://dx.doi.org/10.1111/cea.12748] [PMID: 27144664]
[26]
Orhan F, Canitez Y, Bakirtas A, et al. Anaphylaxis in turkish children: A multi-centre, retrospective, case study. Clin Exp Allergy 2011; 41(12): 1767-76.
[http://dx.doi.org/10.1111/j.1365-2222.2011.03859.x] [PMID: 22092675]
[27]
Pouessel G, Tanno LK, Claverie C, et al. Fatal anaphylaxis in children in france: Analysis of national data. Pediatr Allergy Immunol 2018; 29(1): 101-4.
[http://dx.doi.org/10.1111/pai.12828] [PMID: 29047172]
[28]
Jerschow E, Lin RY, Scaperotti MM, McGinn AP. Fatal anaphylaxis in the United States, 1999-2010: Temporal patterns and demographic associations. J Allergy Clin Immunol 2014; 134(6): 1318-28.
[http://dx.doi.org/10.1016/j.jaci.2014.08.018] [PMID: 25280385]
[29]
Xing Y, Zhang H, Sun S, et al. Clinical features and treatment of pediatric patients with drug-induced anaphylaxis: A study based on pharmacovigilance data. Eur J Pediatr 2018; 177(1): 145-54.
[http://dx.doi.org/10.1007/s00431-017-3048-z] [PMID: 29168013]
[30]
Leonardi S, Pecoraro R, Filippelli M, et al. Allergic reactions to foods by inhalation in children. Allergy Asthma Proc 2014; 35(4): 288-94.
[http://dx.doi.org/10.2500/aap.2014.35.3755] [PMID: 24992548]
[31]
Vetander M, Helander D, Flodström C, et al. Anaphylaxis and reactions to foods in children - a population-based case study of emergency department visits. Clin Exp Allergy 2012; 42(4): 568-77.
[http://dx.doi.org/10.1111/j.1365-2222.2011.03954.x] [PMID: 22417215]
[32]
Kim SY, Kim MH, Cho YJ. Different clinical features of anaphylaxis according to cause and risk factors for severe reactions. Allergol Int 2018; 67(1): 96-102.
[http://dx.doi.org/10.1016/j.alit.2017.05.005] [PMID: 28602247]
[33]
Simons FER, Sampson HA. Anaphylaxis: Unique aspects of clinical diagnosis and management in infants (birth to age 2 years). J Allergy Clin Immunol 2015; 135(5): 1125-31.
[http://dx.doi.org/10.1016/j.jaci.2014.09.014] [PMID: 25441636]
[34]
Rudders SA, Banerji A, Vassallo MF, Clark S, Camargo CA Jr. Trends in pediatric emergency department visits for food-induced anaphylaxis. J Allergy Clin Immunol 2010; 126(2): 385-8.
[http://dx.doi.org/10.1016/j.jaci.2010.05.018] [PMID: 20621344]
[35]
Simons FER, Ardusso LRF, Bilò MB, et al. 2012 Update: World Allergy Organization Guidelines for the assessment and management of anaphylaxis. Curr Opin Allergy Clin Immunol 2012; 12(4): 389-99.
[http://dx.doi.org/10.1097/ACI.0b013e328355b7e4] [PMID: 22744267]
[36]
Anagnostou K. Anaphylaxis in children: Eepidemiology, risk factors and management. Curr Pediatr Rev 2018; 14(3): 180-6.
[http://dx.doi.org/10.2174/1573396314666180507115115] [PMID: 29732976]
[37]
Kahveci M, Akarsu A, Koken G, Sahiner UM, Soyer O, Sekerel BE. Food-induced anaphylaxis in infants, as compared to toddlers and preschool children in Turkey. Pediatr Allergy Immunol 2020; 31(8): 954-61.
[http://dx.doi.org/10.1111/pai.13320] [PMID: 32804444]
[38]
Tan JW, Campbell DE. Insect allergy in children. J Paediatr Child Health 2013; 49(9): E381-7.
[http://dx.doi.org/10.1111/jpc.12178] [PMID: 23586469]
[39]
Golden DBK. Anaphylaxis to insect stings. Immunol Allergy Clin North Am 2015; 35(2): 287-302.
[http://dx.doi.org/10.1016/j.iac.2015.01.007] [PMID: 25841552]
[40]
Bilò BM, Bonifazi F. Epidemiology of insect-venom anaphylaxis. Curr Opin Allergy Clin Immunol 2008; 8(4): 330-7.
[http://dx.doi.org/10.1097/ACI.0b013e32830638c5] [PMID: 18596590]
[41]
Novembre E, Cianferoni A, Bernardini R, et al. Epidemiology of insect venom sensitivity in children and its correlation to clinical and atopic features. Clin Exp Allergy 1998; 28(7): 834-8.
[http://dx.doi.org/10.1046/j.1365-2222.1998.00313.x] [PMID: 9720817]
[42]
Worm M, Moneret-Vautrin A, Scherer K, et al. First European data from the network of severe allergic reactions (NORA). Allergy 2014; 69(10): 1397-404.
[http://dx.doi.org/10.1111/all.12475] [PMID: 24989080]
[43]
Atanaskovic-Markovic M, Gomes E, Cernadas JR, et al. Diagnosis and management of drug-induced anaphylaxis in children: An EAACI position paper. Pediatr Allergy Immunol 2019; 30(3): 269-76.
[http://dx.doi.org/10.1111/pai.13034] [PMID: 30734362]
[44]
Khan DA, Solensky R. Drug allergy. J Allergy Clin Immunol 2010; 125(2): S126-37.
[http://dx.doi.org/10.1016/j.jaci.2009.10.028] [PMID: 20176256]
[45]
Khaleva E, Franz A, Garvey LH, et al. Perioperative anaphylaxis in children: Etiology, time sequence, and patterns of clinical reactivity. Pediatr Allergy Immunol 2020; 31(1): 85-94.
[http://dx.doi.org/10.1111/pai.13124] [PMID: 31518461]
[46]
Wakimoto M, Miller R, Kim SS, et al. Perioperative anaphylaxis in children: A report from the wake‐up safe collaborative. Paediatr Anaesth 2021; 31(2): 205-12.
[http://dx.doi.org/10.1111/pan.14063] [PMID: 33141983]
[47]
Ebisawa M, Ito K, Fujisawa T. Committee for Japanese Pediatric Guideline for Food Allergy, The Japanese Society of Pediatric Allergy and Clinical Immunology, The Japanese Society of Allergology, Japanese guidelines for food allergy 2017. Allergol Int 2017; 66(2): 248-64.
[http://dx.doi.org/10.1016/j.alit.2017.02.001] [PMID: 28285847]
[48]
Benito-Garcia F, Ansotegui IJ, Morais-Almeida M. Diagnosis and prevention of food-dependent exercise-induced anaphylaxis. Expert Rev Clin Immunol 2019; 15(8): 849-56.
[http://dx.doi.org/10.1080/1744666X.2019.1642747] [PMID: 31305164]
[49]
Asaumi T, Ebisawa M. How to manage food dependent exercise induced anaphylaxis (FDEIA). Curr Opin Allergy Clin Immunol 2018; 18(3): 243-7.
[http://dx.doi.org/10.1097/ACI.0000000000000442] [PMID: 29629955]
[50]
Gaspar Â, Santos N, Faria E, et al. Anaphylaxis in children and adolescents: The portuguese anaphylaxis registry. Pediatr Allergy Immunol 2021; 32(6): 1278-86.
[http://dx.doi.org/10.1111/pai.13511] [PMID: 33774834]
[51]
Bohlke K, Davis RL, Marcy SM, et al. Risk of anaphylaxis after vaccination of children and adolescents. Pediatrics 2003; 112(4): 815-20.
[http://dx.doi.org/10.1542/peds.112.4.815] [PMID: 14523172]
[52]
Frenck RW Jr, Klein NP, Kitchin N, et al. Safety, Immunogenicity, and efficacy of the BNT162b2 COVID-19 vaccine in adolescents. N Engl J Med 2021; 385(3): 239-50.
[http://dx.doi.org/10.1056/NEJMoa2107456] [PMID: 34043894]
[53]
Carter MC, Akin C, Castells MC, Scott EP, Lieberman P. Idiopathic anaphylaxis yardstick. Ann Allergy Asthma Immunol 2020; 124(1): 16-27.
[http://dx.doi.org/10.1016/j.anai.2019.08.024] [PMID: 31513910]
[54]
Gonzalez-Estrada A, Silvers SK, Klein A, Zell K, Wang XF, Lang DM. Epidemiology of anaphylaxis at a tertiary care center. Ann Allergy Asthma Immunol 2017; 118(1): 80-5.
[http://dx.doi.org/10.1016/j.anai.2016.10.025] [PMID: 28007089]
[55]
Wright CD, Longjohn M, Lieberman PL, Lieberman JA. An analysis of anaphylaxis cases at a single pediatric emergency department during a 1-year period. Ann Allergy Asthma Immunol 2017; 118(4): 461-4.
[http://dx.doi.org/10.1016/j.anai.2017.02.002] [PMID: 28390586]
[56]
Hogan MB, Kelly MA, Wilson NW. Idiopathic anaphylaxis in children. Ann Allergy Asthma Immunol 1998; 81(2): 140-2.
[http://dx.doi.org/10.1016/S1081-1206(10)62800-1] [PMID: 9723559]
[57]
Turner PJ, Baumert JL, Beyer K, et al. Can we identify patients at risk of life-threatening allergic reactions to food? Allergy 2016; 71(9): 1241-55.
[http://dx.doi.org/10.1111/all.12924] [PMID: 27138061]
[58]
Olabarri M, Vazquez P, Gonzalez-Posada A, et al. Risk factors for severe anaphylaxis in children. J Pediatr 2020; 225: 193-7.
[http://dx.doi.org/10.1016/j.jpeds.2020.06.021] [PMID: 32544480]
[59]
Turner PJ, Jerschow E, Umasunthar T, Lin R, Campbell DE, Boyle RJ. Fatal anaphylaxis: Mortality rate and risk factors. J Allergy Clin Immunol Pract 2017; 5(5): 1169-78.
[http://dx.doi.org/10.1016/j.jaip.2017.06.031] [PMID: 28888247]
[60]
Reber LL, Hernandez JD, Galli SJ. The pathophysiology of anaphylaxis. J Allergy Clin Immunol 2017; 140(2): 335-48.
[http://dx.doi.org/10.1016/j.jaci.2017.06.003] [PMID: 28780941]
[61]
Muraro A, Roberts G, Clark A, et al. The management of anaphylaxis in childhood: Position paper of the European Academy of Allergology and Clinical Immunology. Allergy 2007; 62(8): 857-71.
[http://dx.doi.org/10.1111/j.1398-9995.2007.01421.x] [PMID: 17590200]
[62]
González-Pérez A, Aponte Z, Vidaurre CF, Rodríguez LAG. Anaphylaxis epidemiology in patients with and patients without asthma: A United Kingdom database review. J Allergy Clin Immunol 2010; 125(5): 1098-104.
[http://dx.doi.org/10.1016/j.jaci.2010.02.009] [PMID: 20392483]
[63]
Bock SA, Muñoz-Furlong A, Sampson HA. Fatalities due to anaphylactic reactions to foods. J Allergy Clin Immunol 2001; 107(1): 191-3.
[http://dx.doi.org/10.1067/mai.2001.112031] [PMID: 11150011]
[64]
Calvani M, Cardinale F, Martelli A, et al. Risk factors for severe pediatric food anaphylaxis in Italy. Pediatr Allergy Immunol 2011; 22(8): 813-9.
[http://dx.doi.org/10.1111/j.1399-3038.2011.01200.x] [PMID: 21929598]
[65]
Burks AW, Jones SM, Boyce JA, et al. NIAID-sponsored 2010 guidelines for managing food allergy: Applications in the pediatric population. Pediatrics 2011; 128(5): 955-65.
[http://dx.doi.org/10.1542/peds.2011-0539] [PMID: 21987705]
[66]
Noimark L, Wales J, Du Toit G, et al. The use of adrenaline autoinjectors by children and teenagers. Clin Exp Allergy 2012; 42(2): 284-92.
[http://dx.doi.org/10.1111/j.1365-2222.2011.03912.x] [PMID: 22181034]
[67]
Clark S, Wei W, Rudders SA, Camargo CA Jr. Risk factors for severe anaphylaxis in patients receiving anaphylaxis treatment in US emergency departments and hospitals. J Allergy Clin Immunol 2014; 134(5): 1125-30.
[http://dx.doi.org/10.1016/j.jaci.2014.05.018] [PMID: 24985399]
[68]
Ring J, Beyer K, Biedermann T, et al. Guideline (S2k) on acute therapy and management of anaphylaxis: 2021 update. Allergo J Int 2021; 30(1): 1-25.
[http://dx.doi.org/10.1007/s40629-020-00158-y] [PMID: 33527068]
[69]
Bilò MB, Martini M, Tontini C, Corsi A, Antonicelli L. Anaphylaxis. Eur Ann Allergy Clin Immunol 2020; 53(1): 4-17.
[http://dx.doi.org/10.23822/EurAnnACI.1764-1489.158] [PMID: 32550734]
[70]
Shaker MS, Wallace DV, Golden DBK, et al. Anaphylaxis - a 2020 practice parameter update, systematic review, and grading of recommendations, assessment, development and evaluation (GRADE) analysis. J Allergy Clin Immunol 2020; 145(4): 1082-123.
[http://dx.doi.org/10.1016/j.jaci.2020.01.017] [PMID: 32001253]
[71]
Ikegawa K, Morikawa E, Nigo A, Hataya H, Akasawa A. Epidemiology of anaphylaxis and biphasic reaction in Japanese children. Acute Med Surg 2021; 8(1): e688.
[http://dx.doi.org/10.1002/ams2.688] [PMID: 34327006]
[72]
Lee S, Bellolio MF, Hess EP, Erwin P, Murad MH, Campbell RL. Time of onset and predictors of biphasic anaphylactic reactions: A systematic review and meta-analysis. J Allergy Clin Immunol Pract 2015; 3(3): 408-416.e2, 2.
[http://dx.doi.org/10.1016/j.jaip.2014.12.010] [PMID: 25680923]
[73]
Anagnostou K, Turner PJ. Myths, facts and controversies in the diagnosis and management of anaphylaxis. Arch Dis Child 2019; 104(1): 83-90.
[http://dx.doi.org/10.1136/archdischild-2018-314867] [PMID: 29909382]
[74]
Simons FER, Ebisawa M, Sanchez-Borges M, et al. 2015 update of the evidence base: World Allergy Organization anaphylaxis guidelines. World Allergy Organ J 2015; 8(1): 32.
[http://dx.doi.org/10.1186/s40413-015-0080-1] [PMID: 26525001]
[75]
Brown SGA. Clinical features and severity grading of anaphylaxis. J Allergy Clin Immunol 2004; 114(2): 371-6.
[http://dx.doi.org/10.1016/j.jaci.2004.04.029] [PMID: 15316518]
[76]
Carlisle A, Lieberman J. Clinical management of infant anaphylaxis. J Asthma Allergy 2021; 14: 821-7.
[http://dx.doi.org/10.2147/JAA.S286692] [PMID: 34267527]
[77]
Cardenas-Morales M, Hernandez-Trujillo V. Infant anaphylaxis: A diagnostic challenge. Curr Allergy Asthma Rep 2021; 21(2): 12.
[http://dx.doi.org/10.1007/s11882-021-00990-4]
[78]
Pouessel G, Jean-Bart C, Deschildre A, et al. Food-induced anaphylaxis in infancy compared to preschool age: A retrospective analysis. Clin Exp Allergy 2020; 50(1): 74-81.
[http://dx.doi.org/10.1111/cea.13519] [PMID: 31651059]
[79]
Lieberman JA, Bingemann TA, Wang J. Diagnostic challenges in anaphylaxis. J Allergy Clin Immunol Pract 2020; 8(4): 1177-84.
[http://dx.doi.org/10.1016/j.jaip.2019.11.003] [PMID: 32276686]
[80]
Simons FER, Ardusso LRF, Bilò MB, et al. World allergy organization guidelines for the assessment and management of anaphylaxis. World Allergy Organ J 2011; 4(2): 13-37.
[http://dx.doi.org/10.1097/WOX.0b013e318211496c] [PMID: 23268454]
[81]
Campbell RL, Hagan JB, Manivannan V, et al. Evaluation of national institute of allergy and infectious diseases/food allergy and anaphylaxis network criteria for the diagnosis of anaphylaxis in emergency department patients. J Allergy Clin Immunol 2012; 129(3): 748-52.
[http://dx.doi.org/10.1016/j.jaci.2011.09.030] [PMID: 22051698]
[82]
de Silva D, Singh C, Muraro A, et al. Diagnosing, managing and preventing anaphylaxis: Systematic review. Allergy 2021; 76(5): 1493-506.
[http://dx.doi.org/10.1111/all.14580] [PMID: 32880997]
[83]
Turner PJ, Campbell DE, Motosue MS, Campbell RL. Global trends in anaphylaxis epidemiology and clinical implications. J Allergy Clin Immunol Pract 2020; 8(4): 1169-76.
[http://dx.doi.org/10.1016/j.jaip.2019.11.027] [PMID: 31786255]
[84]
Turner PJ, Worm M, Ansotegui IJ, et al. Time to revisit the definition and clinical criteria for anaphylaxis? World Allergy Organ J 2019; 12(10): 100066.
[http://dx.doi.org/10.1016/j.waojou.2019.100066] [PMID: 31719946]
[85]
Lieberman P, Nicklas RA, Oppenheimer J, et al. The diagnosis and management of anaphylaxis practice parameter: 2010 update. J Allergy Clin Immunol 2010; 126(3): 477-80.
[86]
Campbell RL, Li JTC, Nicklas RA, Sadosty AT. Emergency department diagnosis and treatment of anaphylaxis: A practice parameter. Ann Allergy Asthma Immunol 2014; 113(6): 599-608.
[http://dx.doi.org/10.1016/j.anai.2014.10.007] [PMID: 25466802]
[87]
Wilson JM, Schuyler AJ, Workman L, et al. Investigation into the α-Gal Syndrome: Characteristics of 261 children and adults reporting red meat allergy. J Allergy Clin Immunol Pract 2019; 7(7): 2348-2358.e4.
[http://dx.doi.org/10.1016/j.jaip.2019.03.031] [PMID: 30940532]
[88]
Martelli A, Ghiglioni D, Sarratud T, et al. Anaphylaxis in the emergency department: A paediatric perspective. Curr Opin Allergy Clin Immunol 2008; 8(4): 321-9.
[http://dx.doi.org/10.1097/ACI.0b013e328307a067] [PMID: 18596589]
[89]
Simons F, Frew A, Ansotegui I, et al. Risk assessment in anaphylaxis: Current and future approaches. J Allergy Clin Immunol 2007; 120(1): S2-S24.
[http://dx.doi.org/10.1016/j.jaci.2007.05.001] [PMID: 17602945]
[90]
Jimenez-Rodriguez T, Garcia-Neuer M, Alenazy LA, Castells M. Anaphylaxis in the 21st century: Phenotypes, endotypes, and biomarkers. J Asthma Allergy 2018; 11: 121-42.
[http://dx.doi.org/10.2147/JAA.S159411] [PMID: 29950872]
[91]
Weiler CR, Austen KF, Akin C, et al. AAAAI mast cell disorders committee work group report: Mast cell activation syndrome (MCAS) diagnosis and management. J Allergy Clin Immunol 2019; 144(4): 883-96.
[http://dx.doi.org/10.1016/j.jaci.2019.08.023] [PMID: 31476322]
[92]
Simons FER, Ardusso LRF, Bilò MB, et al. International consensus on (ICON) anaphylaxis. World Allergy Organ J 2014; 7(1): 9.
[http://dx.doi.org/10.1186/1939-4551-7-9] [PMID: 24920969]
[93]
Valent P, Akin C, Arock M, et al. Definitions, criteria and global classification of mast cell disorders with special reference to mast cell activation syndromes: A consensus proposal. Int Arch Allergy Immunol 2012; 157(3): 215-25.
[http://dx.doi.org/10.1159/000328760] [PMID: 22041891]
[94]
Ono E, Taniguchi M, Mita H, et al. Increased production of cysteinyl leukotrienes and prostaglandin D2 during human anaphylaxis. Clin Exp Allergy 2009; 39(1): 72-80.
[http://dx.doi.org/10.1111/j.1365-2222.2008.03104.x] [PMID: 19128354]
[95]
Vadas P, Gold M, Perelman B, et al. Platelet-activating factor, PAF acetylhydrolase, and severe anaphylaxis. N Engl J Med 2008; 358(1): 28-35.
[http://dx.doi.org/10.1056/NEJMoa070030] [PMID: 18172172]
[96]
Santos AF, Du Toit G, Douiri A, et al. Distinct parameters of the basophil activation test reflect the severity and threshold of allergic reactions to peanut. J Allergy Clin Immunol 2015; 135(1): 179-86.
[http://dx.doi.org/10.1016/j.jaci.2014.09.001] [PMID: 25567046]
[97]
Watts MM, Marie Ditto A. Anaphylaxis. Allergy Asthma Proc 2019; 40(6): 453-6.
[http://dx.doi.org/10.2500/aap.2019.40.4270] [PMID: 31690393]
[98]
Boyce JA, Assa’ad A, Burks AW, et al. Guidelines for the diagnosis and management of food allergy in the United States: Summary of the NIAID sponsored expert panel report. J Allergy Clin Immunol 2010; 126(6): 1105-18.
[http://dx.doi.org/10.1016/j.jaci.2010.10.008] [PMID: 21134568]
[99]
Nowak-Węgrzyn A, Katz Y, Mehr SS, Koletzko S. Non–IgE-mediated gastrointestinal food allergy. J Allergy Clin Immunol 2015; 135(5): 1114-24.
[http://dx.doi.org/10.1016/j.jaci.2015.03.025] [PMID: 25956013]
[100]
Farkas H, Martinez-Saguer I, Bork K, et al. International consensus on the diagnosis and management of pediatric patients with hereditary angioedema with C1 inhibitor deficiency. Allergy 2017; 72(2): 300-13.
[http://dx.doi.org/10.1111/all.13001] [PMID: 27503784]
[101]
Poowuttikul P, Seth D. Anaphylaxis in children and adolescents. Pediatr Clin North Am 2019; 66(5): 995-1005.
[http://dx.doi.org/10.1016/j.pcl.2019.06.005] [PMID: 31466687]
[102]
Brockow K, Plata-Nazar K, Lange M, Nedoszytko B, Niedoszytko M, Valent P. Mediator-related symptoms and anaphylaxis in children with mastocytosis. Int J Mol Sci 2021; 22(5): 2684.
[http://dx.doi.org/10.3390/ijms22052684] [PMID: 33799959]
[103]
Valent P, Horny HP, Triggiani M, Arock M. Clinical and laboratory parameters of mast cell activation as basis for the formulation of diagnostic criteria. Int Arch Allergy Immunol 2011; 156(2): 119-27.
[http://dx.doi.org/10.1159/000323763] [PMID: 21576982]
[104]
Carter MC, Metcalfe DD, Komarow HD. Mastocytosis. Immunol Allergy Clin North Am 2014; 34(1): 181-96.
[http://dx.doi.org/10.1016/j.iac.2013.09.001] [PMID: 24262698]
[105]
Pouessel G, Antoine M, Lejeune S, et al. The time course of anaphylaxis manifestations in children is diverse and unpredictable. Clin Exp Allergy 2020; 50(1): 117-20.
[http://dx.doi.org/10.1111/cea.13510] [PMID: 31594029]
[106]
Tham EH, Leung ASY, Pacharn P, et al. Anaphylaxis – Lessons learnt when East meets West. Pediatr Allergy Immunol 2019; 30(7): 681-8.
[http://dx.doi.org/10.1111/pai.13098] [PMID: 31220363]
[107]
Brown JC, Simons E, Rudders SA. Epinephrine in the management of anaphylaxis. J Allergy Clin Immunol Pract 2020; 8(4): 1186-95.
[http://dx.doi.org/10.1016/j.jaip.2019.12.015] [PMID: 32276687]
[108]
Tanno LK, Alvarez-Perea A, Pouessel G. Therapeutic approach of anaphylaxis. Curr Opin Allergy Clin Immunol 2019; 19(4): 393-401.
[http://dx.doi.org/10.1097/ACI.0000000000000539] [PMID: 31058676]
[109]
Song TT, Lieberman P. Epinephrine in anaphylaxis. Curr Opin Allergy Clin Immunol 2015; 15(4): 323-8.
[http://dx.doi.org/10.1097/ACI.0000000000000185] [PMID: 26110682]
[110]
Frith K, Smith J, Joshi P, Ford LS, Vale S. Updated anaphylaxis guidelines: Management in infants and children. Aust Prescr 2021; 44(3): 91-5.
[http://dx.doi.org/10.18773/austprescr.2021.016] [PMID: 34211247]
[111]
Shaker MS, Oppenheimer J, Wallace DV, et al. Making the GRADE in anaphylaxis management. Ann Allergy Asthma Immunol 2020; 124(6): 526-535.e2.
[http://dx.doi.org/10.1016/j.anai.2020.03.009] [PMID: 32199979]
[112]
Cox L, Larenas-Linnemann D, Lockey RF, Passalacqua G. Speaking the same language: The World Allergy Organization subcutaneous immunotherapy systemic reaction grading system. J Allergy Clin Immunol 2010; 125(3): 569-74.
[113]
Sánchez-Borges M, Ansotegui I, Cox L. World Allergy Organization grading system for systemic allergic reactions: It is time to speak the same language when it comes to allergic reactions. Curr Treat Options Allergy 2019; 6(4): 388-95.
[http://dx.doi.org/10.1007/s40521-019-00229-8]
[114]
Cox LS, Sanchez-Borges M, Lockey RF. World Allergy Organization systemic allergic reaction grading system: Is a modification needed? J Allergy Clin Immunol Pract 2017; 5(1): 58-62.e5.
[http://dx.doi.org/10.1016/j.jaip.2016.11.009] [PMID: 28065342]
[115]
Robinson M, Greenhawt M, Stukus DR. Factors associated with epinephrine administration for anaphylaxis in children before arrival to the emergency department. Ann Allergy Asthma Immunol 2017; 119(2): 164-9.
[http://dx.doi.org/10.1016/j.anai.2017.06.001] [PMID: 28711194]
[116]
Lieberman P, Decker W, Camargo CA Jr, O’Connor R, Oppenheimer J, Simons FE. SAFE: A multidisciplinary approach to anaphylaxis education in the emergency department. Ann Allergy Asthma Immunol 2007; 98(6): 519-23.
[http://dx.doi.org/10.1016/S1081-1206(10)60729-6] [PMID: 17601263]
[117]
Muraro A, Clark A, Beyer K, et al. The management of the allergic child at school: EAACI/GA2LEN Task Force on the allergic child at school. Allergy 2010; 65(6): 681-9.
[http://dx.doi.org/10.1111/j.1398-9995.2010.02343.x] [PMID: 20345502]
[118]
Muraro A, Agache I, Clark A, et al. EAACI Food Allergy and Anaphylaxis Guidelines: Managing patients with food allergy in the community. Allergy 2014; 69(8): 1046-57.
[http://dx.doi.org/10.1111/all.12441] [PMID: 24905609]
[119]
Simons FER, Clark S, Camargo CA Jr. Anaphylaxis in the community: Learning from the survivors. J Allergy Clin Immunol 2009; 124(2): 301-6.
[http://dx.doi.org/10.1016/j.jaci.2009.03.050] [PMID: 19540575]
[120]
Lieberman JA, Camargo CA Jr, Pistiner M, Wang J. Pediatrician perspectives on symptom presentation and treatment of acute allergic reactions. Ann Allergy Asthma Immunol 2021; 126(3): 273-7.
[http://dx.doi.org/10.1016/j.anai.2020.11.010] [PMID: 33232828]
[121]
Eigenmann PA, Akdis C, Bousquet J, Grattan CE, Hoffmann-Sommergruber K, Jutel M. Food and drug allergy, and anaphylaxis in EAACI journals (2018). Pediatr Allergy Immunol 2019; 30(8): 785-94.
[http://dx.doi.org/10.1111/pai.13125] [PMID: 31539176]
[122]
Muraro A, Werfel T, Hoffmann-Sommergruber K, et al. EAACI food allergy and anaphylaxis guidelines: Diagnosis and management of food allergy. Allergy 2014; 69(8): 1008-25.
[http://dx.doi.org/10.1111/all.12429] [PMID: 24909706]
[123]
Calamelli E, Liotti L, Beghetti I, Piccinno V, Serra L, Bottau P. Component-resolved diagnosis in food allergies. Medicina 2019; 55(8): 498.
[http://dx.doi.org/10.3390/medicina55080498] [PMID: 31426616]
[124]
Järvinen KM, Celestin J. Anaphylaxis avoidance and management: Educating patients and their caregivers. J Asthma Allergy 2014; 7: 95-104.
[http://dx.doi.org/10.2147/JAA.S48611] [PMID: 25031541]
[125]
Skypala IJ. Food-induced anaphylaxis: Role of hidden allergens and cofactors. Front Immunol 2019; 10: 673.
[http://dx.doi.org/10.3389/fimmu.2019.00673] [PMID: 31001275]
[126]
Pajno GB, Fernandez-Rivas M, Arasi S, et al. EAACI Guidelines on allergen immunotherapy: IgE-mediated food allergy. Allergy 2018; 73(4): 799-815.
[http://dx.doi.org/10.1111/all.13319] [PMID: 29205393]
[127]
Kidon M, Blanca-Lopez N, Gomes E, et al. EAACI/ENDA position paper: Diagnosis and management of hypersensitivity reactions to non-steroidal anti-inflammatory drugs (NSAIDs) in children and adolescents. Pediatr Allergy Immunol 2018; 29(5): 469-80.
[http://dx.doi.org/10.1111/pai.12915] [PMID: 29693290]
[128]
Doña I, Pérez-Sánchez N, Eguiluz-Gracia I, et al. Progress in understanding hypersensitivity reactions to nonsteroidal anti-inflammatory drugs. Allergy 2020; 75(3): 561-75.
[http://dx.doi.org/10.1111/all.14032] [PMID: 31469167]
[129]
Savic LC, Garvey LH. Perioperative anaphylaxis: Diagnostic challenges and management. Curr Opin Anaesthesiol 2020; 33(3): 448-53.
[http://dx.doi.org/10.1097/ACO.0000000000000857] [PMID: 32371637]
[130]
Stepanovic B, Sommerfield D, Lucas M, Ungern-Sternberg BS. An update on allergy and anaphylaxis in pediatric anesthesia. Paediatr Anaesth 2019; 29(9): 892-900.
[http://dx.doi.org/10.1111/pan.13703] [PMID: 31379063]
[131]
Torres MJ, Trautmann A, Böhm I, et al. Practice parameters for diagnosing and managing iodinated contrast media hypersensitivity. Allergy 2021; 76(5): 1325-39.
[http://dx.doi.org/10.1111/all.14656] [PMID: 33170954]
[132]
Brockow K, Sánchez-Borges M. Hypersensitivity to contrast media and dyes. Immunol Allergy Clin North Am 2014; 34(3): 547-64. viii.
[http://dx.doi.org/10.1016/j.iac.2014.04.002] [PMID: 25017677]
[133]
Salas M, Gomez F, Fernandez TD, et al. Diagnosis of immediate hypersensitivity reactions to radiocontrast media. Allergy 2013; 68(9): 1203-6.
[http://dx.doi.org/10.1111/all.12214] [PMID: 23991759]
[134]
Caubet JC, Rudzeviciene O, Gomes E, Terreehorst I, Brockow K, Eigenmann PA. Managing a child with possible allergy to vaccine. Pediatr Allergy Immunol 2014; 25(4): 394-403.
[http://dx.doi.org/10.1111/pai.12132] [PMID: 24131271]
[135]
Dreskin SC, Halsey NA, Kelso JM, et al. International Consensus (ICON): Allergic reactions to vaccines. World Allergy Organ J 2016; 9(1): 32.
[http://dx.doi.org/10.1186/s40413-016-0120-5] [PMID: 27679682]
[136]
Zheng YJ, Wang XC, Feng LZ, et al. Expert consensus on COVID-19 vaccination in children. World J Pediatr 2021; 17(5): 449-57.
[http://dx.doi.org/10.1007/s12519-021-00465-6] [PMID: 34618327]
[137]
Sokolowska M, Eiwegger T, Ollert M, et al. EAACI statement on the diagnosis, management and prevention of severe allergic reactions to COVID-19 vaccines. Allergy 2021; 76(6): 1629-39.
[http://dx.doi.org/10.1111/all.14739] [PMID: 33452689]
[138]
Feldweg AM. Exercise-induced anaphylaxis. Immunol Allergy Clin North Am 2015; 35(2): 261-75.
[http://dx.doi.org/10.1016/j.iac.2015.01.005] [PMID: 25841550]
[139]
Povesi Dascola C, Caffarelli C. Exercise-induced anaphylaxis: A clinical view. Ital J Pediatr 2012; 38(1): 43.
[http://dx.doi.org/10.1186/1824-7288-38-43] [PMID: 22980517]
[140]
Castells MC. Anaphylaxis: Watch out, it is everywhere now! Ann Allergy Asthma Immunol 2020; 124(2): 116-7.
[http://dx.doi.org/10.1016/j.anai.2019.12.013] [PMID: 32029208]
[141]
Akin C. Mast cell activation syndromes presenting as anaphylaxis. Immunol Allergy Clin North Am 2015; 35(2): 277-85.
[http://dx.doi.org/10.1016/j.iac.2015.01.010] [PMID: 25841551]
[142]
Frew AJ. What are the ‘ideal’ features of an adrenaline (epinephrine) auto-injector in the treatment of anaphylaxis? Allergy 2011; 66(1): 15-24.
[http://dx.doi.org/10.1111/j.1398-9995.2010.02450.x] [PMID: 20716315]
[143]
Kim H, Dinakar C, McInnis P, et al. Inadequacy of current pediatric epinephrine autoinjector needle length for use in infants and toddlers. Ann Allergy Asthma Immunol 2017; 118(6): 719-725.e1.
[http://dx.doi.org/10.1016/j.anai.2017.03.017] [PMID: 28483294]
[144]
Lieberman JA, Wang J. Epinephrine in anaphylaxis: Too little, too late. Curr Opin Allergy Clin Immunol 2020; 20(5): 452-8.
[http://dx.doi.org/10.1097/ACI.0000000000000680] [PMID: 32739981]
[145]
Le M, Gabrielli S, De Schryver S, Ben-Shoshan M. Management strategies of idiopathic anaphylaxis in the emergency room: Current perspectives. Open Access Emerg Med 2019; 11: 249-63.
[http://dx.doi.org/10.2147/OAEM.S200342] [PMID: 31802955]
[146]
Greenberger PA, Lieberman P. Idiopathic anaphylaxis. J Allergy Clin Immunol Pract 2014; 2(3): 243-50.
[http://dx.doi.org/10.1016/j.jaip.2014.02.012] [PMID: 24811012]
[147]
Lieberman PL. Idiopathic anaphylaxis. Allergy Asthma Proc 2014; 35(1): 17-23.
[http://dx.doi.org/10.2500/aap.2014.35.3717] [PMID: 24433593]
[148]
Liu D, Ahmet A, Ward L, et al. A practical guide to the monitoring and management of the complications of systemic corticosteroid therapy. Allergy Asthma Clin Immunol 2013; 9(1): 30.
[http://dx.doi.org/10.1186/1710-1492-9-30] [PMID: 23947590]
[149]
Gulen T, Akin C. Idiopathic anaphylaxis: A Perplexing diagnostic challenge for allergists. Curr Allergy Asthma Rep 2021; 21(2): 11.
[http://dx.doi.org/10.1007/s11882-021-00988-y] [PMID: 33560495]
[150]
Warrier P, Casale TB. Omalizumab in idiopathic anaphylaxis. Ann Allergy Asthma Immunol 2009; 102(3): 257-8.
[http://dx.doi.org/10.1016/S1081-1206(10)60091-9] [PMID: 19354075]
[151]
Tanno LK, Demoly P. Biologicals for the prevention of anaphylaxis. Curr Opin Allergy Clin Immunol 2021; 21(3): 303-8.
[http://dx.doi.org/10.1097/ACI.0000000000000737] [PMID: 33625038]
[152]
Tanno LK, Martin B. Biologic agents for the treatment of anaphylaxis. Immunol Allergy Clin North Am 2020; 40(4): 625-33.
[http://dx.doi.org/10.1016/j.iac.2020.06.006] [PMID: 33012324]
[153]
Pouessel G, Dumond P, Liabeuf V, et al. Gaps in the management of food-induced anaphylaxis reactions at school. Pediatr Allergy Immunol 2019; 30(7): 767-70.
[http://dx.doi.org/10.1111/pai.13091] [PMID: 31172595]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy